Skip to content
HowShorted

BioXcel Therapeutics, Inc. short interest in 2020

In 2020, BioXcel Therapeutics, Inc.'s disclosed short interest ran from 2.53% of shares outstanding on 15 Jan 2020 to 13.66% on 31 Dec 2020, a change of +11.13 percentage points. The year's high was 13.92% on 31 Jul 2020 and its low 2.34% on 14 Feb 2020, averaging 7.92% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.17 days on 30 Nov 2020. Full history: BioXcel Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for BioXcel Therapeutics, Inc. in 2020

2020 in figures

Start of year
2.53% (15 Jan 2020)
End of year
13.66% (31 Dec 2020)
Change
+11.13 pp
High
13.92% (31 Jul 2020)
Low
2.34% (14 Feb 2020)
Average
7.92%
Highest days to cover
9.17 (30 Nov 2020)

Every report in 2020

BioXcel Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20202.53%1.00
31 Jan 20202.45%2.17
14 Feb 20202.34%1.00
28 Feb 20202.70%1.00
13 Mar 20203.80%1.03
31 Mar 20203.00%1.21
15 Apr 20203.25%1.81
30 Apr 20204.22%1.89
15 May 20203.87%1.88
29 May 20203.34%1.96
15 Jun 20204.68%2.96
30 Jun 202011.09%3.91
15 Jul 202010.69%5.96
31 Jul 202013.92%2.70
14 Aug 202010.79%4.43
31 Aug 20209.64%3.65
15 Sep 202010.30%4.77
30 Sep 202012.04%5.76
15 Oct 202010.40%4.99
30 Oct 202012.65%6.30
13 Nov 202012.11%7.63
30 Nov 202013.41%9.17
15 Dec 202013.09%8.81
31 Dec 202013.66%7.78

See also: BioXcel Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.